Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk
Josep Rodés‐Cabau(Institut universitaire de cardiologie et de pneumologie de Québec), Eric Horlick(University of Toronto), Daniel Doyle(Community Health Systems - Dupont Hospital), Mark Osten(University of Toronto), Éric Dumont(Lung Institute), Robert DeLarochellière(Université Laval), Giuseppe Martucci(Royal Victoria Hospital), Benoît DeVarennes(Royal Victoria Hospital), John G. Webb(St. Paul's Hospital), Mark D. Peterson(NYU Langone Health), Asim N. Cheema(Southlake Regional Health Center), Kevin Lachapelle(Royal Victoria Hospital), Adrian Dancea(Montreal Children's Hospital), James L. Velianou(Hamilton General Hospital), David A. Latter(St. Michael's Hospital), Victor Chu(Hamilton General Hospital), Christopher M. Feindel(University of Toronto), Jian Ye(Taizhou Municipal Hospital), Robert J. Chisholm(St. Michael's Hospital), Kevin Teoh(McMaster University), Samuel V. Lichtenstein(University of British Columbia), Anson Cheung(St. Paul's Hospital), Fabian Nietlispach(University of Zurich), Madhu K. Natarajan(Hamilton General Hospital)
Cited by 973
Related Papers
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
|European Heart Journal|2011|1.2k
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785
Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
|Journal of the American College of Cardiology|2011|734
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|687